Skip to main content
Equibles

MARSHALL WACE, LLP

Position in AXGN — Axogen, Inc.

CIK 1318757 LONDON, X0
Back to AXGN Full portfolio

Position in AXGN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$13,778,522
+$12,660,319 QoQ
Shares Held
298,301
+783.8% QoQ
Ownership
0.555%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#47
of 253 holders
Holding Since
Jun 2020
11 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in AXGN Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $951,017,652 across 59 Medical Devices names. AXGN ranks #10 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 5,542,438 $502,920,823
2 BSX
Boston Scientific Corp
 2,414,223 $103,039,037
3 GKOS
GLAUKOS Corp
 314,804 $43,997,006
4 DXCM
Dexcom Inc
 532,804 $35,884,349
5 EW
Edwards Lifesciences Corp
 344,361 $31,150,895
6 PEN
Penumbra Inc
 90,520 $28,581,689
7 SYK
Stryker Corp
 51,116 $16,093,361
8 GMED
Globus Medical Inc
 188,541 $14,896,623

All Filings in AXGN

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,778,522 298,301
2026-03-31 $1,118,203 33,752
2025-12-31 $4,935,356 150,790
2025-09-30 $3,341,574 187,308
2025-06-30 $6,959,558 641,434
2025-03-31 $12,362,717 668,255
2024-12-31 $1,509,418 91,591
2024-09-30 $1,547,162 110,354
2022-03-31 $483,728 60,923
2021-12-31 $1,779,756 189,942
2020-06-30 $807,123 87,351